DE69103068T2 - Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält. - Google Patents

Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält.

Info

Publication number
DE69103068T2
DE69103068T2 DE69103068T DE69103068T DE69103068T2 DE 69103068 T2 DE69103068 T2 DE 69103068T2 DE 69103068 T DE69103068 T DE 69103068T DE 69103068 T DE69103068 T DE 69103068T DE 69103068 T2 DE69103068 T2 DE 69103068T2
Authority
DE
Germany
Prior art keywords
alpha
therapeutic agent
pyridylalkane
urinate
urge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69103068T
Other languages
English (en)
Other versions
DE69103068D1 (de
Inventor
Masaaki Tomoi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of DE69103068D1 publication Critical patent/DE69103068D1/de
Application granted granted Critical
Publication of DE69103068T2 publication Critical patent/DE69103068T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE69103068T 1990-04-18 1991-04-11 Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält. Expired - Fee Related DE69103068T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10390390 1990-04-18

Publications (2)

Publication Number Publication Date
DE69103068D1 DE69103068D1 (de) 1994-09-01
DE69103068T2 true DE69103068T2 (de) 1995-01-05

Family

ID=14366388

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69103068T Expired - Fee Related DE69103068T2 (de) 1990-04-18 1991-04-11 Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält.

Country Status (11)

Country Link
US (1) US5202331A (de)
EP (1) EP0452809B1 (de)
JP (1) JP2500821B2 (de)
KR (1) KR100190823B1 (de)
AT (1) ATE109003T1 (de)
AU (1) AU641747B2 (de)
CA (1) CA2040680A1 (de)
DE (1) DE69103068T2 (de)
DK (1) DK0452809T3 (de)
TW (1) TW214546B (de)
ZA (1) ZA912589B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998002432A1 (en) * 1996-07-16 1998-01-22 Takeda Chemical Industries, Ltd. Bicyclic compounds for controlling micturition
AU2001256714A1 (en) * 2000-05-15 2001-11-26 Kissei Pharmaceutical Co. Ltd. Water-based liquid preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5980664A (ja) * 1982-09-30 1984-05-10 Fujisawa Pharmaceut Co Ltd α−アリ−ル−α−ピリジル脂肪酸誘導体およびその製法
US4857535A (en) * 1986-01-09 1989-08-15 United Pharmaceuticals Anti-spasmodic agents having a heterocyclic ring
DE3601196A1 (de) * 1986-01-17 1987-07-23 Merck Patent Gmbh 1,4-dihydropyridine
US4957941A (en) * 1987-11-16 1990-09-18 United Pharmaceuticals, Inc. Anti-spasmdoic agents having an acetylenic bond
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof

Also Published As

Publication number Publication date
KR100190823B1 (ko) 1999-06-01
US5202331A (en) 1993-04-13
DK0452809T3 (da) 1994-09-05
JP2500821B2 (ja) 1996-05-29
AU641747B2 (en) 1993-09-30
AU7506591A (en) 1991-10-24
ATE109003T1 (de) 1994-08-15
EP0452809A2 (de) 1991-10-23
EP0452809A3 (en) 1992-04-15
TW214546B (de) 1993-10-11
JPH059118A (ja) 1993-01-19
KR910018026A (ko) 1991-11-30
DE69103068D1 (de) 1994-09-01
ZA912589B (en) 1992-01-29
CA2040680A1 (en) 1991-10-19
EP0452809B1 (de) 1994-07-27

Similar Documents

Publication Publication Date Title
NO890723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo(3.2.0)hept2-en-2-karboksylsyrederivater.
SE9604786D0 (sv) New compounds
BR0211228A (pt) Composto, composição farmacêutica e seus usos
ATE109149T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen.
ES8705886A1 (es) Un metodo para preparar un derivadode tiazolidin-diona
DE68916071T2 (de) 3-Pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en-2-carbonsäure-Verbindungen.
ES499870A0 (es) Un procedimiento para la preparacion de derivados de indano
FI921522A (fi) Pyrazolopyridinfoerening och foerfarande foer dess framstaellning
ATE161531T1 (de) Acridine-1,8-dionderivate als therapeutisches mittel
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
NO905620L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
DE69103068D1 (de) Therapeutisches Mittel gegen Pollakiurie, Harndrang oder Harninkontinenz, das alpha-Phenyl-alpha-Pyridylalkan-Carbonsäurederivate enthält.
EP0503079A4 (en) Pyridazinone-substituted ethynylphenyl derivative and remedy for circulatory organ disease containing the same as active ingredient
ZA928876B (en) Thiazole derivatives.
SG4595G (en) Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure
DE69011174D1 (de) Catecholaminester.
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
DK214884A (da) Chlorphenoxyacetatderivat
IT1245390B (it) Composizione farmaceutica ad attivita' antivirale

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee